Goldman Sachs analyst, Salveen Richter, reiterated a Buy rating and $315.00 price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) following a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Pre-Open Movers 09/18: (VKTX) (NXEO) (TLRY) Higher; (MDGL) (ATHN) (CBRL) Lower (more...)September 18, 2018 9:24 AM Madrigal Pharma (MDGL) Set to Open Lower Following Viking DataSeptember 18, 2018 7:46 AM